Laboratorios Farmaceuticos Rovi, S.A.
LABFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $4 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4 | $4 | $4 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 31.8% | 3.1% | -22.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 70.2% | 65.9% | 58.4% | 54.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 39.9% | 19.5% | 19.5% | 16.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 27.6% | 13.5% | 11.7% | 11.7% |
| EPS Diluted | 1.13 | 0.42 | 0.35 | 1.81 |
| % Growth | 169% | 20% | -80.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |